< Back to previous page
Researcher
Benoit Beuselinck
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Feb 2011 → Today
Projects
1 - 6 of 6
- Response prediction in metastatic clear-cell renal cell carcinoma treated with angiogenesis and/or immune checkpoint inhibitorsFrom1 Oct 2020 → TodayFunding: Foundations, funds and other with scientific goal
- Medication-related osteonecrosis of the jaw (MRONJ) - Balancing treatments benefits and risksFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- RESPONSE PREDICTION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TARGETED THERAPY AND/OR IMMUNE CHECKPOINT INHIBITORSFrom5 Dec 2019 → 30 Sep 2021Funding: BOF - projects
- RESPONSE PREDICTION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTORTARGETED THERAPY AND/OR IMMUNE CHECKPOINT INHIBITORSFrom1 Oct 2019 → TodayFunding: FWO fellowships
- Patient selection strategies throughout the renal cell carcinoma disease spectrumFrom1 Aug 2019 → 6 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular profiling of clear-cell renal cell carcinoma and prediction of response to targeted therapies against the vascular endothelial growth factor receptor, immune checkpoint inhibitors and mTOR inhibitors in the metastatic setting.From1 Oct 2016 → 30 Sep 2020Funding: FWO fellowships, Nonprofit institution or equivalents
Publications
1 - 10 of 152
- Trial watch: chemotherapy-induced immunogenic cell death in oncology(2023)
Authors: Jenny Sprooten, Isaure Vanmeerbeek, Stefan Naulaerts, Lisa Kinget, An Coosemans, Steven De Vleeschouwer, Els Wauters, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, et al.
- Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma treated with first-line combination immunotherapies: Results from the International metastatic renal cell carcinoma database consortium (IMDC)(2023)
Authors: Benoit Beuselinck
Pages: S1558 - S1559 - Comparison of cabozantinib (CABO) versus sunitinib (SUN) following first-line (1L) nivolumab plus ipilimumab (NIVO plus IPI) for metastatic renal cell carcinoma (mRCC): A target trial emulation using real-world data from the International mRCC Database Consortium (IMDC)(2023)
Authors: Benoit Beuselinck
Pages: S1023 - S1024 - Multi-omics mapping positions antigenic myeloid-T cell crosstalk at the core of advanced renal cell carcinoma (aRCC) response to immune checkpoint blockade (ICB)(2023)
Authors: Lisa Kinget, Isaure Vanmeerbeek, Diether Lambrechts, Bram Boeckx, Maarten Albersen, Sabine Tejpar, Benoit Beuselinck, Abhishek Garg
Pages: S1026 - S1027 - Safety and efficacy of two doses of belzutifan in patients (pts) with advanced RCC: Results of the randomized phase II LITESPARK-013 study(2023)
Authors: Benoit Beuselinck
Pages: S1011 - S1011 - Pseudoprogression and Mixed Responses in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab: A Retrospective Analysis(2023)
Authors: Marcella Baldewijns, Maarten Albersen, Gert De Meerleer, Benoit Beuselinck
Pages: 442 - 451 - Metastatic renal cell carcinoma to the pancreas and other sites -a multicenter retrospective study(2023)
Authors: Benoit Beuselinck
- Efficacy of first-line (1L) immunotherapy (IO)-based regimens in patients with sarcomatoid and/or rhabdoid (S/R) metastatic non-clear cell renal cell carcinoma (nccRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).(2023)
Authors: Benoit Beuselinck
- Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents-A retrospective study of 240 patients(2023)
Authors: Evelien Gielen, Constantinus Politis, Benoit Beuselinck
- Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium(2023)
Authors: Benoit Beuselinck
Pages: 701 - 709